Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Borgestad Q2 FY26 profit before tax rises to MNOK 35.9; Höganäs Borgestad EBIT climbs to MNOK 36.8

Borgestad Q2 FY26 profit before tax rises to MNOK 35.9; Höganäs Borgestad EBIT climbs to MNOK 36.8

ReutersReuters2026/08/14 05:11
  • Borgestad posted Q2 2026 profit before tax of NOK 35.9 million, up from adjusted NOK 20.9 million a year earlier.
  • Höganäs Borgestad revenue slipped to NOK 290.4 million; EBIT climbed to NOK 36.8 million versus adjusted NOK 22.1 million.
  • Agora Bytom revenue fell 5% to NOK 19.9 million; EBITDA declined to NOK 10.9 million.
  • Agora Bytom occupancy stood at 97.4% on signed leases as of June 30, 2026.
  • Newly signed tenants are expected to open in the second half of 2026, supporting growth in the center’s financial performance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Borgestad ASA published the original content used to generate this news brief on August 14, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas